1. Lifetime Risk of Venous Thromboembolism in Two Cohort Studies
Elizabeth J. Bell, PhD, MPH, Pamela L. Lutsey, PhD, MPH, Saonli Basu, PhD, MStat, Mary Cushman, MD, MSc, Susan R. Heckbert, PhD, MD, MPH, Donald M. Lloyd-Jones, MD, ScM, Aaron R. Folsom, MD, MPH 
The American Journal of Medicine 
Volume 129, Issue 3, Pages 339.e e26 (March 2016)
DOI: /j.amjmed
Copyright © 2016 Elsevier Inc. Terms and Conditions

2. Figure
Cohort- and age- specific venous thromboembolism incidence rates by time period of venous thromboembolism ascertainment. ARIC = Atherosclerosis Risk in Communities study; CHS = Cardiovascular Health Study.
The American Journal of Medicine  , 339.e e26DOI: ( /j.amjmed )
Copyright © 2016 Elsevier Inc. Terms and Conditions

3. Supplementary Figure
Cumulative risk of VTE at selected index ages (A) by cohort and, in ARIC, for race- and sex-specific groups (B-E), with death considered a competing event. Lifetime risk for a given index age is cumulative risk through 85 years of age. ARIC = Atherosclerosis Risk in Communities study; CHS = Cardiovascular Health Study; VTE = venous thromboembolism.
The American Journal of Medicine  , 339.e e26DOI: ( /j.amjmed )
Copyright © 2016 Elsevier Inc. Terms and Conditions